Around 10,000 Americans are diagnosed with a malignant glioma every year. And, unfortunately, they received an almost inevitable death sentence. Glioma, types of tumors which grow in the brain or spine, are virtually incurable and the average one-year survival rate after diagnosis is only about 50 percent.
But now there is finally hope for a new and effective treatment. A compound known as hypericin, originally discovered in the herb St. John’s wort.
In findings just published in the journal Cancer, scientists are reporting that synthetic hypericin strongly inhibits the growth of gliomas. The reason appears to be, at least in part, because hypericin inhibits protein Continue reading